相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reciprocal signaling between mTORC1 and MNK2 controls cell growth and oncogenesis
Jianling Xie et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Antisense Oligonucleotides As Potential Therapeutics for Type 2 Diabetes
Suxiang Chen et al.
NUCLEIC ACID THERAPEUTICS (2021)
Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain
Muhammad Saad Yousuf et al.
PHARMACOLOGICAL REVIEWS (2021)
Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E
Ram Kumar et al.
ANTIVIRAL RESEARCH (2021)
ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation
Hui-er Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma
Xin-Yu Ke et al.
ONCOGENE (2021)
Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation
Joseph-Patrick W. E. Clarke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Topography of transcriptionally active chromatin in glioblastoma
Liang Xu et al.
SCIENCE ADVANCES (2021)
A Comprehensive Analysis of the Role of hnRNP A1 Function and Dysfunction in the Pathogenesis of Neurodegenerative Disease
Joseph P. Clarke et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Progress in developing MNK inhibitors
Xin Jin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Mnk inhibitors: a patent review
Ahmed M. Abdelaziz et al.
PHARMACEUTICAL PATENT ANALYST (2021)
First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
Vincenzo Teneggi et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2
Jacek Kwiatkowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Nicotinamide-Ponatinib Analogues as Potent Anti-CML and Anti-AML Compounds
Elizabeth Larocque et al.
ACS OMEGA (2020)
Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
Celia Pinto-Diez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity
Lauren Y. Sandeman et al.
MOLECULAR METABOLISM (2020)
Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity
Thao N. D. Pham et al.
CANCERS (2020)
The Impact of ALS-Associated GeneshnRNPA1,MATR3,VCPandUBQLN2on the Severity of TDP-43 Aggregation
Ana Bajc Cesnik et al.
CELLS (2020)
IL-6 induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition
Vivek Jeevakumar et al.
JOURNAL OF NEUROPHYSIOLOGY (2020)
Rescue of oxytocin response and social behaviour in a mouse model of autism
Hanna Hornberg et al.
NATURE (2020)
Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia
Liang-Chieh Chen et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Targeting translation
Katharine H. Wrighton
NATURE REVIEWS DRUG DISCOVERY (2020)
A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions
Erin E. Gallagher et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Therapeutic Antisense Oligonucleotides Are Coming of Age
C. Frank Bennett
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation
Theodosia Charitou et al.
BRITISH JOURNAL OF CANCER (2019)
Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G
Erin E. Gallagher et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated β-Catenin Activation
Weijia Zhang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d] pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma
Min Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a] pyridine]-1',5'-dione derivatives as Mnk inhibitors
Ahmed M. Abdelaziz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of novel Mnk inhibitors using mutation-based induced-fit virtual high-throughput screening
Rama K. Mishra et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold
Xin Jin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
Jonathan B. Bell et al.
MOLECULAR CANCER RESEARCH (2018)
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Carlo Rinaldi et al.
NATURE REVIEWS NEUROLOGY (2018)
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
Ka Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
Yonghui Sun et al.
CELL RESEARCH (2018)
Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
Chengwei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Phthalimide conjugations for the degradation of oncogenic PI3K
Wenlu Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
Siegfried H. Reich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia
Haiyan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Adelajda Zorba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
Argel Aguilar-Valles et al.
NATURE COMMUNICATIONS (2018)
Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells
Ella Lineham et al.
Oncotarget (2018)
A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1
Yumi Matsui et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2018)
eIF4E Phosphorylation in Prostate Cancer
Leandro S. D'Abronzo et al.
NEOPLASIA (2018)
Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response
Craig R. Stumpf et al.
CANCER RESEARCH (2018)
The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
Ines S. Amorim et al.
FRONTIERS IN GENETICS (2018)
eIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity
Sonali Uttam et al.
FRONTIERS IN GENETICS (2018)
Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas
Weibing Fan et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers
Ella Lineham et al.
FUTURE MEDICINAL CHEMISTRY (2017)
The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain
Jamie K. Moy et al.
JOURNAL OF NEUROSCIENCE (2017)
Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation
Brian C. Avanzino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Translational Dysregulation in Cancer: Molecular insights and Potential Clinical Applications in Biomarker Development
Christos Vaklavas et al.
FRONTIERS IN ONCOLOGY (2017)
Small Molecules Targeting the Inactive Form of the Mnk1/2 Kinases
Srinivasaraghavan Kannan et al.
ACS OMEGA (2017)
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Agnieszka Dreas et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Caroline M. Robb et al.
CHEMICAL COMMUNICATIONS (2017)
BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity
Susann Santag et al.
CANCER LETTERS (2017)
Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
H. Wu et al.
LEUKEMIA (2016)
Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer
Krishan Kumar et al.
MOLECULAR CANCER RESEARCH (2016)
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
Michal Grzmil et al.
CELLULAR SIGNALLING (2016)
Unveiling new chemical scaffolds as Mnk inhibitors
Sarah Diab et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
Wooseok Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells
Joseph Cherian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma
Jonathan B. Bell et al.
MOLECULAR CANCER RESEARCH (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding
James E. Beggs et al.
BIOCHEMICAL JOURNAL (2015)
Differential Requirements for eIF4E Dose in Normal Development and Cancer
Morgan L. Truitt et al.
CELL (2015)
An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis
Theodosia Teo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation
Mingfeng Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Dynamical insights of Mnk2 kinase activation by phosphorylation to facilitate inhibitor discovery
Malika Kumarasiri et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Knockdown of eukaryotic translation initiation factor 4E suppresses cell growth and invasion, and induces apoptosis and cell cycle arrest in a human lung adenocarcinoma cell line
Baofu Chen et al.
MOLECULAR MEDICINE REPORTS (2015)
Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations
Srinivasaraghavan Kannan et al.
BIOCHEMISTRY (2015)
Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2
Sunita K. C. Basnet et al.
MOLECULAR PHARMACOLOGY (2015)
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Jigisha P. Thakkar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
MAP Kinase-Interacting Kinases-Emerging Targets against Cancer
Sarah Diab et al.
CHEMISTRY & BIOLOGY (2014)
Discovery of 5-( 2-( Phenylamino) pyrimidin-4-yl) thiazol2( 3H)- one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
Sarah Diab et al.
CHEMMEDCHEM (2014)
The Herpes Simplex Virus 1 Virion Host Shutoff Protein Enhances Translation of Viral Late mRNAs by Preventing mRNA Overload
Bianca Dauber et al.
JOURNAL OF VIROLOGY (2014)
Induction of Viral, 7-Methyl-Guanosine Cap-Independent Translation and Oncolysis by Mitogen-Activated Protein Kinase-Interacting Kinase-Mediated Effects on the Serine/Arginine-Rich Protein Kinase
Michael C. Brown et al.
JOURNAL OF VIROLOGY (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Synaptic proteins and receptors defects in autism spectrum disorders
Jianling Chen et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Autism genetics
Antonio M. Persico et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Rational Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by Tuning the Reactivity of an Enamide Michael Acceptor
Jin Xu et al.
CHEMMEDCHEM (2013)
hnRNP A1: The Swiss Army Knife of Gene Expression
Jacques Jean-Philippe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
S. Betty Yan et al.
INVESTIGATIONAL NEW DRUGS (2013)
Autism-related deficits via dysregulated eIF4E-dependent translational control
Christos G. Gkogkas et al.
NATURE (2013)
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway
L. Adesso et al.
ONCOGENE (2013)
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
Sharon Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Rational Optimization of Conformational Effects Induced By Hydrocarbon Staples in Peptides and their Binding Interfaces
Dilraj Lama et al.
SCIENTIFIC REPORTS (2013)
Cap-Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target
Yan Jia et al.
MEDICINAL RESEARCH REVIEWS (2012)
Improved eIF4E Binding Peptides by Phage Display Guided Design: Plasticity of Interacting Surfaces Yield Collective Effects
Weizhuang Zhou et al.
PLOS ONE (2012)
Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases
Bruce W. Konicek et al.
CANCER RESEARCH (2011)
IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells CRITICAL ROLE OF CYTOPLASMIC LOCALIZATION OF THE RNA-BINDING PROTEIN hnRNP A1
Yijiang Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Exploring Aigialomycin D and Its Analogues as Protein Kinase Inhibitors for Cancer Targets
Jin Xu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues
Georgios Boukakis et al.
BMC CANCER (2010)
Sumoylation of eIF4E activates mRNA translation
Xiang Xu et al.
EMBO REPORTS (2010)
HDAC2 Promotes eIF4E Sumoylation and Activates mRNA Translation Gene Specifically
Xiang Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
Luc Furic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
eIF4E: New Family Members, New Binding Partners, New Roles
Robert E. Rhoads
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
Robert M. Rowlett et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells
Andrea Bianchini et al.
CARCINOGENESIS (2008)
The Autistic Neuron: Troubled Translation?
Raymond J. Kelleher et al.
CELL (2008)
eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling
Alpana Soni et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Dissecting eIF4E action in tumorigenesis
Hans-Guido Wendel et al.
GENES & DEVELOPMENT (2007)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity
Jeremy R. Graff et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Characterization of the activity of human MAP kinase-interacting kinase Mnk1b
Ana O'Loghlen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment
Ralf Jauch et al.
EMBO JOURNAL (2006)
hnRNP A1 relocalization to the stress granules reflects a role in the stress response
Sonia Guil et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Regulation of sprouty stability by Mnk1-dependent phosphorylation
J DaSilva et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas
ND Hendrix et al.
CANCER RESEARCH (2006)
Posttranscriptional regulation of TNFα expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages
K Andersson et al.
CYTOKINE (2006)
eIF4E as a marker for cervical neoplasia
J Matthews-Greer et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site
R Jauch et al.
STRUCTURE (2005)
The Mnks are novel components in the control of TNFα biosynthesis and phosphorylate and regulate hnRNP A1
M Buxadé et al.
IMMUNITY (2005)
High-resolution genome-wide mapping of genetic alterations in human glial brain tumors
M Bredel et al.
CANCER RESEARCH (2005)
eIF-4E expression and its role in malignancies and metastases
A De Benedetti et al.
ONCOGENE (2004)
eIF4E - from translation to transformation
Y Mamane et al.
ONCOGENE (2004)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells
D Walsh et al.
GENES & DEVELOPMENT (2004)
Phosphorylation of Mnk1 by caspase-activated pak2/γ-PAK inhibits phosphorylation and interaction of eIF4G with Mnk
KC Orton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development
T Ueda et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells
J Worch et al.
ONCOGENE (2004)
Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology
A Pellagatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
D Ruggero et al.
NATURE MEDICINE (2004)
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis
I Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs
JR Graff et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation?
GC Scheper et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Clinical relevance of MGMT in the treatment of cancer
SL Gerson
JOURNAL OF CLINICAL ONCOLOGY (2002)
Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases
Y Hefner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection
L Hou et al.
INFECTION AND IMMUNITY (2000)
Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme
D Osoba et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
